BAYLESS JON W 3
Accession 0001179110-11-011259
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 8:00 PM ET
Size
19.8 KB
Accession
0001179110-11-011259
Insider Transaction Report
- (indirect: See Footnote)
Series 2 Preferred Stock
Exercise: $0.00→ Common Stock (2,368,403 underlying) - (indirect: See Footnote)
Series 1 Preferred Stock
Exercise: $0.00→ Common Stock (11,139,646 underlying) Stock Options (Right To Buy)
Exercise: $4.72From: 2011-04-14Exp: 2020-04-16→ Common Stock (18,455 underlying)Stock Option (Right To Buy)
Exercise: $5.99From: 2012-01-28Exp: 2021-01-28→ Common Stock (18,455 underlying)- 86,135(indirect: See Footnote)
Common Stock
- 86,135(indirect: See Footnote)
Common Stock
Stock Options (Right To Buy)
Exercise: $4.72From: 2011-04-14Exp: 2020-04-16→ Common Stock (18,455 underlying)Stock Option (Right To Buy)
Exercise: $5.99From: 2012-01-28Exp: 2021-01-28→ Common Stock (18,455 underlying)- (indirect: See Footnote)
Series 1 Preferred Stock
Exercise: $0.00→ Common Stock (11,139,646 underlying) - (indirect: See Footnote)
Series 2 Preferred Stock
Exercise: $0.00→ Common Stock (2,368,403 underlying)
- 86,135(indirect: See Footnote)
Common Stock
Stock Options (Right To Buy)
Exercise: $4.72From: 2011-04-14Exp: 2020-04-16→ Common Stock (18,455 underlying)Stock Option (Right To Buy)
Exercise: $5.99From: 2012-01-28Exp: 2021-01-28→ Common Stock (18,455 underlying)- (indirect: See Footnote)
Series 1 Preferred Stock
Exercise: $0.00→ Common Stock (11,139,646 underlying) - (indirect: See Footnote)
Series 2 Preferred Stock
Exercise: $0.00→ Common Stock (2,368,403 underlying)
- (indirect: See Footnote)
Series 2 Preferred Stock
Exercise: $0.00→ Common Stock (2,368,403 underlying) Stock Options (Right To Buy)
Exercise: $4.72From: 2011-04-14Exp: 2020-04-16→ Common Stock (18,455 underlying)Stock Option (Right To Buy)
Exercise: $5.99From: 2012-01-28Exp: 2021-01-28→ Common Stock (18,455 underlying)- (indirect: See Footnote)
Series 1 Preferred Stock
Exercise: $0.00→ Common Stock (11,139,646 underlying) - 86,135(indirect: See Footnote)
Common Stock
Stock Options (Right To Buy)
Exercise: $4.72From: 2011-04-14Exp: 2020-04-16→ Common Stock (18,455 underlying)Stock Option (Right To Buy)
Exercise: $5.99From: 2012-01-28Exp: 2021-01-28→ Common Stock (18,455 underlying)- 86,135(indirect: See Footnote)
Common Stock
- (indirect: See Footnote)
Series 1 Preferred Stock
Exercise: $0.00→ Common Stock (11,139,646 underlying) - (indirect: See Footnote)
Series 2 Preferred Stock
Exercise: $0.00→ Common Stock (2,368,403 underlying)
- (indirect: See Footnote)
Series 2 Preferred Stock
Exercise: $0.00→ Common Stock (2,368,403 underlying) - 86,135(indirect: See Footnote)
Common Stock
Stock Options (Right To Buy)
Exercise: $4.72From: 2011-04-14Exp: 2020-04-16→ Common Stock (18,455 underlying)Stock Option (Right To Buy)
Exercise: $5.99From: 2012-01-28Exp: 2021-01-28→ Common Stock (18,455 underlying)- (indirect: See Footnote)
Series 1 Preferred Stock
Exercise: $0.00→ Common Stock (11,139,646 underlying)
- 86,135(indirect: See Footnote)
Common Stock
- (indirect: See Footnote)
Series 2 Preferred Stock
Exercise: $0.00→ Common Stock (2,368,403 underlying) Stock Option (Right To Buy)
Exercise: $5.99From: 2012-01-28Exp: 2021-01-28→ Common Stock (18,455 underlying)- (indirect: See Footnote)
Series 1 Preferred Stock
Exercise: $0.00→ Common Stock (11,139,646 underlying) Stock Options (Right To Buy)
Exercise: $4.72From: 2011-04-14Exp: 2020-04-16→ Common Stock (18,455 underlying)
Footnotes (6)
- [F1]Stock Options are fully vested and exercisable on the first anniversary date of the grant.
- [F2]Each share of Series 1 Preferred Stock automatically converts into common stock at the closing of an initial public offering on a 1-for-3.522 basis.
- [F3]Each share of Series 2 Preferred Stock automatically converts into common stock at the closing of an initial public offering on a 1-for-3.522 basis.
- [F4]Total common shares of 86,135, represents 79,847 of such common shares held by Sevin Rosen Fund VI L.P. (SRFVI) and 6,288 of such common shares held by Sevin Rosen VI Affiliates Fund L.P. (SRVI AFF). Stephen M. Dow (Dow), Stephen L. Domenik (Domenik), Jon W. Bayless (Bayless), John V. Jaggers (Jaggers) and Charles H. Phipps (Phipps) are general partners of the general partner of SRFVI and SRVI AFF. Messers Dow, Domenik, Bayless, Jaggers and Phipps disclaim beneficial ownership of these shares except to the extent of his proportionate partnership interest in these shares.
- [F5]Total Series 1 Preferred shares of 11,139,646 represents 5,598,525 of such preferred shares held by Sevin Rosen Fund VI L.P. (SRFVI), 440,876 of such preferred shares held by Sevin Rosen VI Affiliates Fund L.P. (SRVI AFF), 4,998,240 of such preferred shares held by Sevin Rosen Fund VIII L.P. (SRFVIII) and 102,005 of such preferred shares held by Sevin Rosen VIII Affiliates Fund L.P. (SRVIII AFF). Dow, Domenik, Bayless, Jaggers and Phipps are general partners of the general partner of SRFVI and SRVI AFF. Dow, Domenik, Bayless, Jaggers, Phipps, Jackie R. Kimzey (Kimzey) and Alan R. Schuele (Schuele) are general partners of the general partner of SRFVIII and SRVIII AFF. Messers Dow, Domenik, Bayless, Jaggers, Phipps, Kimzey and Schuele disclaim beneficial ownership of these shares except to the extent of his proportionate partnership interest in these shares.
- [F6]Total Series 2 Preferred shares of 2,368,403 represents 2,321,036 of such preferred shares held by Sevin Rosen Fund VIII L.P. (SRFVIII) and 47,367 of such preferred shares held by Sevin Rosen VIII Affiliates Fund L.P. (SRVIII AFF). Dow, Domenik, Bayless, Jaggers, Phipps, Kimzey and Schuele are general partners of the general partner of SRFVIII and SRVIII AFF. Messers Dow, Domenik, Bayless, Jaggers, Phipps, Kimzey and Schuele disclaim beneficial ownership of these shares except to the extent of his proportionate partnership interest in these shares.
Documents
Issuer
TANGOE INC
CIK 0001182325
Related Parties
1- filerCIK 0001026496
Filing Metadata
- Form type
- 3
- Filed
- Jul 25, 8:00 PM ET
- Accepted
- Jul 26, 8:00 PM ET
- Size
- 19.8 KB